War demands extraordinary levels of physical endurance, concentration and psychological resilience. Soldiers may be expected to march for hours, remain awake through the night, operate under extreme stress and continue fighting despite exhaustion. Throughout history, military organisations and individual combatants have turned to substances they believed could help them meet these demands.
Some drugs were distributed under military supervision when their long-term risks were poorly understood. Others were obtained illegally, used without authorisation or circulated through black markets. Several substances that once appeared useful for military performance later became associated with dependence, serious health consequences and strict legal controls.
The history is more complicated than the popular image of soldiers taking drugs to become fearless fighters. Stimulants could temporarily reduce fatigue, while opioids were used to treat battlefield injuries. Neither effect meant that the drugs made soldiers reliably better at fighting. Sleep deprivation, impaired judgement, addiction and other complications could ultimately undermine military effectiveness.
This article examines five substances associated with wartime drug use: methamphetamine, amphetamine, cocaine, heroin and opium, and Captagon-type stimulants. It distinguishes documented military distribution from illicit use and disputed allegations, because a drug used during a war is not necessarily one officially approved by an army.
Military drug use has never had a single explanation. Different substances have served different purposes, from keeping exhausted troops awake to relieving severe injuries or coping with the psychological pressures of combat.
A further distinction matters in any serious investigation: a drug can be medically prescribed, distributed by military authorities, prohibited for unauthorised use or obtained illegally on the battlefield. These are different situations, and treating them as interchangeable would distort the historical evidence.
Historical context: Germany and Japan during World War II.
Methamphetamine is one of the most widely discussed stimulants in the history of military drug use. Its wartime reputation is closely associated with Nazi Germany, where it was sold under the brand name Pervitin, and with Japan, where methamphetamine products were also used during the Second World War.
The drug stimulates the central nervous system. It can increase wakefulness and reduce the subjective sensation of fatigue, which made it attractive in an era when military operations often required long periods without adequate rest.
Methamphetamine was synthesised in Germany in 1937 and commercially released in 1938. Pervitin subsequently became popular among civilians as well as military personnel. During World War II, some German commanders distributed it to exhausted troops to help them remain awake and continue operating.
A historical review by Ray J. Defalque and Amos J. Wright, indexed by the US National Library of Medicine, documents this military use. The authors also explain that methamphetamine use was subject to restrictions and that some commanders distributed it despite objections from medical personnel. The popular claim that the Nazi government systematically promoted Pervitin to create a generation of superhuman soldiers is not supported by the evidence presented in that review.
Read the historical review: Methamphetamine for Hitler’s Germany: 1937 to 1945.
The distinction matters because historical accounts sometimes portray drug use as a single, centrally organised programme. The actual picture was more complicated: military demands, individual commanders’ decisions, medical concerns and evolving restrictions all played a role.
The immediate attraction was straightforward. A soldier who was struggling to remain awake might feel more alert after taking a stimulant. In military operations, where fatigue can interfere with concentration and the ability to carry out routine tasks, that effect appeared useful.
However, feeling awake is not the same as being fully rested. Stimulants do not eliminate the underlying effects of sleep deprivation. A person may remain awake while still suffering from impaired judgement, reduced attention or poor decision-making.
Methamphetamine can also cause anxiety, agitation, elevated heart rate and blood pressure, insomnia and, in some circumstances, paranoia or psychosis. Repeated use can lead to dependence and substantial health risks.
In combat, these effects are particularly concerning. A soldier must not only remain awake but also interpret information accurately, distinguish threats from non-threats and make decisions under pressure. Increased wakefulness does not guarantee any of those abilities.
The wartime experience contributed to a broader recognition that stimulants could carry significant costs. In Japan, military use of methamphetamine during World War II was followed by a serious post-war public health problem. Research on Japan’s methamphetamine history describes how military stockpiles entered civilian circulation after 1945, contributing to widespread misuse.
The lesson: Methamphetamine’s history demonstrates the danger of treating wakefulness as a substitute for sleep. A substance that seems to solve an immediate operational problem can create longer-term medical and behavioural risks.
Historical context: Britain and the United States during World War II.
Amphetamine is chemically related to methamphetamine, although the two are distinct substances. During World War II, amphetamine-based medicines were used by Allied military personnel, including British and American forces, to help manage fatigue and maintain alertness during demanding operations.
One well-known preparation was Benzedrine. Its wartime use illustrates a wider issue in military medicine: the pressure to maintain performance can encourage the adoption of drugs before their benefits and risks are fully understood.
The Second World War involved prolonged air missions, night operations, long-distance travel and other activities that placed considerable demands on military personnel. Fatigue could become an operational concern, particularly when crews needed to remain alert during lengthy missions.
Amphetamine appeared to offer a practical response. It could increase wakefulness and influence mood, confidence and the subjective experience of tiredness.
A peer-reviewed historical study examined the scientific and military reasoning behind the Allies’ adoption of amphetamine. The researchers concluded that the available research did not provide strong grounds for approving the drug as a dependable solution to fatigue. Military decision-makers were also influenced by reports of improved confidence, aggression and morale.
Read the research: Medical Science and the Military: The Allies’ Use of Amphetamine during World War II.
That distinction is important. A substance may make someone feel more energetic or confident without improving the accuracy of their decisions or the quality of their performance.
The answer depends on what is being measured.
Amphetamine can temporarily improve wakefulness and certain aspects of attention in tired individuals. That does not mean every task improves, that the effect is predictable in every person or that prolonged operations become safe.
Potential adverse effects include insomnia, agitation, anxiety, increased heart rate and elevated blood pressure. High doses or prolonged use can produce more serious psychiatric and cardiovascular complications.
There is also a practical problem: using stimulants to extend working hours can encourage commanders or individuals to underestimate how much rest is required. Once the effects wear off, fatigue remains, and the resulting sleep disruption can make recovery more difficult.
For military personnel, the consequences can extend beyond personal health. Errors in navigation, communication, threat assessment or equipment operation may endanger entire teams.
Amphetamine is not universally illegal. Its legal status varies by country, and some amphetamine-based medicines are authorised for specific medical conditions under controlled prescribing arrangements. Non-medical use, unauthorised possession and distribution may be illegal, depending on the jurisdiction.
It would therefore be inaccurate to describe every amphetamine preparation as a banned drug in every country. The historical point is that military use occurred in circumstances where the perceived operational benefits sometimes outweighed the available understanding of the risks.
The lesson: Amphetamine’s wartime history shows why military medicine must distinguish short-term alertness from sustained, safe performance.
Historical context: Europe during World War I.
Cocaine has a long history in medicine, civilian life and military settings. During the early twentieth century, its stimulant effects attracted interest in a period when the risks of non-medical use were not as widely understood as they are today.
World War I created conditions in which fatigue, fear and physical hardship were constant concerns. Some historical accounts describe cocaine use among soldiers and pilots, although the scale of military use is difficult to establish reliably.
Cocaine is a powerful stimulant. It can temporarily increase alertness, reduce appetite and produce feelings of energy or confidence. These effects helped fuel interest in the substance during an era when military planners were searching for ways to sustain human performance under extreme conditions.
An analysis published by the US National Defense University Press describes cocaine’s place in the history of performance-enhancing drugs. It reports that cocaine was used in European military contexts and discusses accounts of its use by pilots and ground troops during World War I.
The same analysis stresses a limitation: reliable records do not establish the full extent of cocaine use across European armies. Historical anecdotes should therefore not be mistaken for proof that every army routinely issued the drug or that it was universally adopted.
Read the analysis: Soldier Enhancement Ethics and the Lessons of World War I.
Cocaine’s reputation as a performance-enhancing drug overlooks its risks.
The stimulant can increase heart rate and blood pressure and constrict blood vessels. It can also cause agitation, anxiety and impulsive behaviour. Serious complications include cardiac arrhythmias, heart attacks, seizures and strokes.
In a combat environment, the potential for overconfidence is especially troubling. A person who feels unusually energetic or fearless may underestimate danger, make rash decisions or misjudge their own physical capabilities.
Cocaine can also produce a powerful cycle of repeated use. As its effects diminish, some users experience exhaustion, low mood and a strong desire to take more. That pattern can undermine the very endurance that the substance was supposed to improve.
Cocaine’s legal history developed gradually, rather than through one universal international ban. Governments introduced restrictions as concerns about dependence, non-medical use and public health grew. International drug-control agreements and national laws subsequently established different systems of control.
Today, cocaine is illegal for non-medical recreational use in many countries, although narrowly defined medical uses may exist under strict regulation in some jurisdictions.
The lesson: Cocaine illustrates how a substance once viewed by some as a useful stimulant can become recognised primarily for its substantial risks when used outside appropriate medical settings.
Historical context: Vietnam War, particularly the late 1960s and early 1970s.
Unlike stimulants, which are associated with wakefulness, heroin and opium belong to the broader history of opioids and their effects on pain, distress and dependence. Their use during wartime reveals a different problem: soldiers may seek relief from psychological pressure as well as physical suffering.
Opium has a long history in medicine, while heroin was originally developed in the nineteenth century and later became widely recognised as a drug with a high potential for dependence. Morphine, another opioid, has also been used extensively to treat severe injuries in military medicine. These substances are related historically, but they are not interchangeable in their effects, medical uses or risks.
During the Vietnam War, illicit drug use became a major concern for the US military and public health authorities. Heroin was available in the surrounding region, and some service members used it during their deployment.
Research indexed by the US National Library of Medicine examined heroin use among American soldiers in Vietnam. A study published in 1977 found that recent heroin use was significantly higher among soldiers in Vietnam than among a comparable military population in the United States, although the proportion who had ever used heroin was similar in the two groups.
Read the research: Research on Heroin Use Among American Soldiers in Vietnam.
Other research documented the relationship between military experiences and the development of heroin dependence. A study of veterans seeking treatment found that Vietnam veterans were more likely than comparison veterans to have begun using heroin during military service. Some participants described using drugs to relieve fear and the tension associated with war.
These findings help explain why heroin use cannot be understood solely as a search for excitement or enhanced performance. For some soldiers, it was connected to the desire to escape an environment characterised by danger, uncertainty and prolonged psychological stress.
It is important to distinguish illicit heroin use from legitimate military pain treatment.
Heroin was not simply an officially prescribed combat-performance drug for American troops in Vietnam. Its use by service members was a recognised problem involving access to illicit substances, individual behaviour and the pressures of deployment.
Morphine, by contrast, has a well-established history as a battlefield analgesic. Military medical personnel have used it to relieve severe pain following traumatic injuries. Research on military medicine also documents the use of opioids for treating casualties in more recent conflicts.
An opioid administered by medical professionals to treat a wounded soldier is not equivalent to a soldier taking illicit heroin to cope with combat stress.
Heroin can cause dependence, sedation and potentially fatal respiratory depression. Overdose risk rises when the substance is mixed with other depressants or when its purity and composition are uncertain.
Long-term use can also have serious consequences for physical health, relationships, employment and psychological wellbeing.
The Vietnam experience nevertheless produced an unexpected finding. Research led by Lee Robins and colleagues followed American service members after their return from Vietnam and found that many who had used narcotics during deployment did not continue using them at the same rate after returning home. This challenged the simplistic assumption that every episode of wartime heroin use inevitably resulted in lifelong dependence. It did not mean that heroin was safe, or that every veteran recovered without difficulty.
Read the research: Follow-up Research on Drug Use Among Vietnam Veterans.
The findings instead highlighted the importance of circumstances. Drug availability, the military environment, individual vulnerabilities, social support and the transition back to civilian life can all influence subsequent patterns of use.
The lesson: Heroin’s history in Vietnam demonstrates that illicit drug use during war can be tied to distress and environmental conditions, while also creating serious risks of addiction and overdose.
Modern context: Syria and the wider Middle East.
Captagon has become one of the most recognisable names in reporting on illicit stimulants in the Middle East. The drug has been linked to extensive trafficking networks, especially those associated with Syria before the fall of Bashar al-Assad’s government in December 2024.
Its association with conflict has also generated claims that fighters have used it to remain awake, suppress hunger or overcome fear. Some accounts have presented it as a kind of chemical shortcut to battlefield aggression. However, the evidence for particular armed groups or individual soldiers using Captagon is uneven, and sensational claims should not be treated as established fact.
Captagon was originally a pharmaceutical brand associated with fenetylline, a synthetic stimulant. The illicit tablets traded today under the Captagon name are not necessarily the original pharmaceutical product. Their chemical composition can vary, and many contain amphetamine in different concentrations alongside other substances.
The United Nations Office on Drugs and Crime (UNODC) has tracked the illicit Captagon market through its World Drug Report series. Its 2025 findings described the market as heavily associated with production and trafficking in Syria and Lebanon, while warning that political changes in Syria had created uncertainty about future supply.
Read the report: UNODC World Drug Report 2025: Key Findings.
The distinction between the original medicine and modern illicit tablets matters. Without laboratory analysis, the name printed or used to describe a tablet cannot reliably establish what it contains.
Amphetamine-type stimulants can temporarily increase wakefulness and reduce appetite. In theory, those effects may appeal to people operating in demanding environments where food, rest and routine are disrupted.
That possibility has contributed to claims about stimulant use among fighters in Syria and elsewhere. But evidence that a drug could produce an effect is not proof that a particular military unit used it, that commanders distributed it or that it improved battlefield performance.
During parliamentary evidence in the United Kingdom, an expert discussing claims about Captagon and Russian forces in Ukraine stated that there was no evidence supporting the specific allegation that Wagner forces were using Captagon.
Read the parliamentary evidence: UK Parliamentary Committee Evidence on Captagon.
That is an important standard for responsible reporting. The presence of a drug in a conflict region, or its use by people connected to an armed group, does not automatically establish that soldiers were supplied with it as part of an organised military programme.
The political transition in Syria substantially affected the reporting and investigation of Captagon production networks.
UNODC’s 2025 reporting described the discovery of major manufacturing sites and the uncertainty surrounding the future of the market. Large seizures in neighbouring countries indicated that trafficking continued, even as the political and security situation changed.
The UNODC’s 2026 World Drug Report continues to track the changing regional synthetic-drug market. Its findings indicate that the market in the Near and Middle East remains dynamic following disruptions to Captagon supply. The report also identifies shifts in the regional balance between amphetamine and methamphetamine seizures.
Explore the data: UNODC World Drug Report 2026.
These are significant developments in the illicit drug trade, but they should not be confused with direct evidence of battlefield consumption. Seizure statistics tell us about trafficking and law-enforcement activity; they do not, by themselves, reveal how many soldiers used a drug or whether it was issued by a commander.
The legal status of substances sold as Captagon depends on their actual chemical contents and the laws of the country concerned. Illicit amphetamine-containing tablets are subject to drug-control laws in many jurisdictions.
The word Captagon is often used loosely in news reports, so responsible coverage should identify whether a claim concerns the original pharmaceutical product, illicit amphetamine tablets or a broader trafficking network.
The lesson: Captagon is a useful case study in the intersection of armed conflict, illicit drug markets and misinformation. Its trafficking is extensively documented, but specific claims about military distribution require separate evidence.
Although the substances differ, their histories reveal a recurring tension between immediate operational demands and long-term human consequences.
| Drug | Historical Association | Reported or Established Context |
|---|---|---|
| Methamphetamine | World War II Germany and Japan | Stimulant use to combat fatigue |
| Amphetamine | Allied forces in World War II | Wakefulness, alertness and morale |
| Cocaine | World War I | Stimulant use reported among some military personnel |
| Heroin and opium | Vietnam War and earlier conflicts | Illicit drug use, distress and the wider history of opioid medicine |
| Captagon-type stimulants | Modern Middle East | Illicit trafficking and disputed claims about combat use |
These categories are not identical. Methamphetamine and amphetamine have documented histories of military distribution; cocaine’s wartime use is supported by historical accounts but its overall scale is uncertain; heroin use among troops in Vietnam was primarily an illicit-drug problem; and Captagon-related military allegations require careful scrutiny.
The common thread is the temptation to use a chemical substance to overcome the limitations of the human body. Yet sleep, recovery, emotional stability and sound judgement remain essential to military performance. No stimulant can reliably eliminate the consequences of prolonged sleep deprivation, and no drug can make combat stress disappear without potential costs.
The question remains relevant in 2026, but modern military medicine is more complex than the historical examples suggest.
Some armed forces use authorised medications under medical supervision for specific clinical needs. Certain military settings have also involved carefully regulated stimulant prescriptions for particular operational circumstances. Such practices are not equivalent to allowing soldiers to use illicit drugs freely.
Modern drug-control systems, military medical policies and substance-testing programmes reflect a greater awareness of the dangers of uncontrolled drug use. Nevertheless, illicit substances remain a concern in military populations, especially where access, stress, trauma and disrupted living conditions create opportunities for misuse.
The UNODC’s 2026 reporting also illustrates why drug trafficking should be analysed separately from military drug policy. Changes in synthetic-drug production and seizure patterns can be documented without assuming that the substances are being used by soldiers.
Explore the latest data: UNODC World Drug Report 2026.
A responsible assessment of any contemporary allegation should ask four questions:
Without those distinctions, reports can turn an established drug-trafficking problem into an unsupported claim about an army’s combat practices.
The historical record offers no simple yes-or-no answer. Stimulants could temporarily reduce the feeling of fatigue, and opioids could relieve severe pain. These effects sometimes appeared useful in circumstances where ordinary medical care and adequate rest were difficult to obtain.
But the costs could be substantial. Stimulants can impair sleep and contribute to anxiety, cardiovascular complications and dependence. Illicit opioids carry risks of addiction and fatal overdose. Even when a drug produces a short-term effect that appears advantageous, the consequences for judgement, health and future functioning may undermine that benefit.
The history of Pervitin, Benzedrine, cocaine and heroin shows how wartime pressures can influence drug use and military medical decisions. Captagon adds a modern example of how illicit markets can become entangled with conflict narratives, propaganda and unverified allegations.
Ultimately, the most important distinction is between a drug’s pharmacological effects, its actual use by soldiers and claims about its military effectiveness. Those are three separate questions, and each requires evidence.
The history of drugs in warfare is not simply a story of soldiers seeking an advantage. It is also a story about the limits of human endurance, the consequences of treating exhaustion as a problem that can be chemically overridden, and the importance of separating verified history from wartime myth.
Editorial note: This article draws on historical research, medical literature and UN reporting available for the 2026 context. The term “banned” is used in the broad editorial sense; the legal status of each substance varies by jurisdiction, formulation and medical use. Claims about drug use by particular armed groups should be updated only when supported by independently verifiable evidence.